PET and optimization of the radiotherapy: How? Which tracers? For what to make?;TEP et optimisation de la radiothérapie : comment ? Quels traceurs ? Pour quoi faire ?

Medecine Nucleaire

Volumn 31, Issue 9, 2007, Pages 516-520

  Giammarile, F ^a  

^a CENTRE HOSPITALIER LYON SUD   (France)

Author keywords

[No Author keywords available]

Indexed keywords

FLUORODEOXYGLUCOSE; TUMOR MARKER; VASCULOTROPIN 121;

APOPTOSIS; ARTICLE; CANCER; CANCER RADIOTHERAPY; CANCER STAGING; CLINICAL PROTOCOL; DOSIMETRY; HUMAN; HYPOXIA; IONIZING RADIATION; NEOVASCULARIZATION (PATHOLOGY); POSITRON EMISSION TOMOGRAPHY; SIMULATION; TREATMENT PLANNING;

EID: 34548265076     PISSN: 09281258     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mednuc.2007.07.007     Document Type: Article

References (42)

1. Greenberger J.S., Kalend A., Sciurba F., Jett J.R., Landreneau R., and Belani C. Development of multifield three-dimensional conformal radiotherapy of lung cancer using a total dose-volume histogram. Radiat Oncol Investig 3 (1996) 243-255
2. Bradley J.D., Perez C.A., Dehdashti F., and Siegel B.A. Implementing biologic target volumes in radiation treatment planning for non-small cell lung cancer. J Nucl Med 45 (2004) 96S-101S
3. Lardinois D., Weder W., Hany T.F., Kamel E.M., Korom S., Seifert B., et al. Staging of non-small-cell lung cancer with integrated positron-emission tomography and computed tomography. N Engl J Med 348 (2003) 2500-2507
4. Boucher L., Rodrigue S., Lecomte R., and Benard F. Respiratory gating for 3-dimensional PET of the thorax: feasibility and initial results. J Nucl Med 45 (2004) 214-219
5. Ciernik I.F., Dizendorf E., Baumert B.G., Reiner B., Burger C., Davis J.B., et al. Radiation treatment planning with an integrated positron emission and computer tomography (PET/CT): a feasibility study. Int J Radiat Oncol Biol Phys 57 (2003) 853-863
6. Dizendorf E.V., Baumert B.G., Von Schulthess G.K., Lutolf U.M., and Steinert H.C. Impact of whole-body 18F-FDG PET on staging and managing patients for radiation therapy. J Nucl Med 44 (2003) 24-29
7. Erdi Y.E., Rosenzweig K., Erdi A.K., Macapinlac H.A., Hu Y.C., Braban L.E., et al. Radiotherapy treatment planning for patients with non-small cell lung cancer using positron emission tomography (PET). Radiother Oncol 62 (2002) 51-60
8. Giraud P., Grahek D., Montravers F., Carette M.F., Deniaud-Alexandre E., Julia F., et al. CT and (18)F-deoxyglucose (FDG) image fusion for optimization of conformal radiotherapy of lung cancers. Int J Radiat Oncol Biol Phys 49 (2001) 1249-1257
9. Kiffer J.D., Berlangieri S.U., Scott A.M., Quong G., Feigen M., Schumer W., et al. The contribution of 18F-fluoro-2-deoxy-glucose positron emission tomographic imaging to radiotherapy planning in lung cancer. Lung Cancer 19 (1998) 167-177
10. Mah K., Caldwell C.B., Ung Y.C., Danjoux C.E., Balogh J.M., Ganguli S.N., et al. The impact of (18)FDG-PET on target and critical organs in CT-based treatment planning of patients with poorly defined non-small-cell lung carcinoma: a prospective study. Int J Radiat Oncol Biol Phys 52 (2002) 339-350
11. Munley M.T., Marks L.B., Scarfone C., Sibley G.S., Patz Jr. E.F., Turkington T.G., et al. Multimodality nuclear medicine imaging in three-dimensional radiation treatment planning for lung cancer: challenges and prospects. Lung Cancer 23 (1999) 105-114
12. Nestle U., Walter K., Schmidt S., Licht N., Nieder C., Motaref B., et al. 18F-deoxyglucose positron emission tomography (FDG-PET) for the planning of radiotherapy in lung cancer: high impact in patients with atelectasis. Int J Radiat Oncol Biol Phys 44 (1999) 593-597
13. Vanuytsel L.J., Vansteenkiste J.F., Stroobants S.G., de Leyn P.R., de Wever W., Verbeken E.K., et al. The impact of (18)F-fluoro-2-deoxy-D-glucose positron emission tomography (FDG-PET) lymph node staging on the radiation treatment volumes in patients with non-small cell lung cancer. Radiother Oncol 55 (2000) 317-324
14. Caldwell C.B., Mah K., Ung Y.C., Danjoux C.E., Balogh J.M., Ganguli S.N., et al. Observer variation in contouring gross tumor volume in patients with poorly defined non-small-cell lung tumors on CT: the impact of 18FDG-hybrid PET fusion. Int J Radiat Oncol Biol Phys 51 (2001) 923-931
15. Nomori H., Watanabe K., Ohtsuka T., Naruke T., Suemasu K., and Uno K. The size of metastatic foci and lymph nodes yielding false-negative and false-positive lymph node staging with positron emission tomography in patients with lung cancer. J Thorac Cardiovasc Surg 127 (2004) 1087-1092
16. Vansteenkiste F., Stroobants S.G., de Leyn P.R., Dupont P.J., Bogaert J., Maes A., et al. Lymph node staging in non-small-cell lung cancer with FDG-PET scan: a prospective study on 690 lymph node stations from 68 patients. J Clin Oncol 16 (1998) 2142-2149
17. Mac Manus M.P., Hicks R.J., Ball D.L., Kalff V., Matthews J.P., Salminen E., et al. F-18-fluorodeoxyglucose positron-emission tomography staging in radical radiotherapy candidates with non-small-cell lung carcinoma. Cancer 92 (2001) 886-895
18. Mac Manus M.P., Wong K., Hicks R., Matthews J.P., Wirth A., and Ball D.L. Early mortality after radiotherapy for non-small-cell lung cancer: comparison of PET-staged and conventionally staged cohorts treated at a large tertiary referral center. Int J Radiat Oncol Biol Phys 52 (2002) 351-361
19. Pieterman R.M., van Putten J.W., Meuzelaar J.J., Mooyaart E.L., Vaalburg W., Koeter G.H., et al. Preoperative staging of non-small-cell lung cancer with positron-emission tomography. N Engl J Med 343 (2000) 254-261
20. Poncelet A.J., Lonneux M., Coche E., Weynand B., and Noirhomme P. PET-FDG scan enhances but does not replace preoperative surgical staging in non-small-cell lung carcinoma. Eur J Cardiothorac Surg 20 (2001) 468-474
21. Holloway C.L., Robinson D., Murray B., Amanie J., Butts C., Smylie M., et al. Results of a phase I study to dose escalate using intensity modulated radiotherapy guided by combined PET/CT imaging with induction chemotherapy for patients with non-small cell lung cancer. Radiother Oncol 73 (2004) 285-287
22. Bradley J., Thorstad W.L., Mutic S., Miller T.R., Dehdashti F., Siegel B.A., et al. Impact of FDG-PET on radiation therapy volume delineation in non-small-cell lung cancer. Int J Radiat Oncol Biol Phys 59 (2004) 78-86
23. Paulino A.C., and Johnstone P.A. FDG-PET in radiotherapy treatment planning: Pandora's box?. Int J Radiat Oncol Biol Phys 59 (2004) 4-5
24. Daisne J.F., Sibomana M., Bol A., Doumont T., Lonneux M., and Gregoire V. Tri-dimensional automatic segmentation of PET volumes based on measured source-to-background ratios: influence of reconstruction algorithms. Radiother Oncol 69 (2003) 247-250
25. Bachaud J.M., Marre D., Dygai I., Caselles O., Hamelin D., Bègue M., et al. Intérêt de la tomographie par émission de positons au [18F]-fluoro-2-désoxyglucose dans la détermination des volumes cibles de radiothérapie. Application à l'irradiation conformationnelle des cancers bronchiques non à petites cellules. Cancer/Radiothérapie 9 (2005) 602-609
26. Caldwell C.B., Mah K., Skinner M., and Danjoux C.E. Can PET provide the 3D extent of tumor motion for individualized internal target volumes? A phantom study of the limitations of CT and the promise of PET. Int J Radiat Oncol Biol Phys 55 (2003) 1381-1393
27. Fox J.L., Rengan R., O'Meara W., Yorke E., Erdi Y., Nehmeh S., et al. Does registration of PET and planning CT images decrease interobserver and intraobserver variation in delineation tumor volumes for non-small-cell lung cancer?. Int J Radiat Oncol Biol Phys 62 (2005) 70-75
28. Goerres G.W., Karnel E., Heidelberg T.N., Schwitter M.R., Burger C., and von Schulthess G.K. PET/CT image coregistration in the thorax: influence of respiration. Eur J Nucl Med 29 (2002) 351-360
29. Cohade C., Osman M., Nakamoto Y., Marshall L.T., Links J.M., Fishman E.K., et al. Initial experience with oral contrast in PET/CT: phantom and clinical studies. J Nucl Med 44 (2003) 412-416
30. Houzard C, Morelec I, Tychyj C, Got P, Rety-Jacob F, Valette PF, et al. Feasibility of iodine contrast enhanced CT-scan during a 18FDG PET-CT study. Eur J Nucl Med (in press: EANM abstract).
31. Mutic S., Malyapa R.S., Grigsby P.W., et al. PET-guided IMRT for cervical carcinoma with positive para-aortic lymph nodes-a dose-escalation treatment planning study. Int J Radiat Oncol Biol Phys 55 (2003) 28-35
32. Gregoire V. Is there any future in radiotherapy planning without the use of PET: unraveling the myth. Radiother Oncol 73 (2004) 261-263
33. Chapman J.D., Bradley J.D., Eary J.F., et al. Molecular (functional) imaging for radiotherapy applications: an RTOG symposium. Int J Radiat Oncol Biol Phys 55 (2003) 294-301
34. 18F]-FLT) est-elle le prochain traceur utilisé en routine pour la TEP après le [18F]-FDG?. Bull Cancer 92 (2005) 789-798
35. Vees H., Buchegger F., Albrecht S., Khan H., Husarik D., Zaidi H., et al. 18F-choline and/or 11C-acetate positron emission tomography: detection of residual or progressive subclinical disease at very low prostate-specific antigen values (<1 ng/mL) after radical prostatectomy. BJU Int 99 (2007) 1415-1420
36. Rajendran J.G., and Krohn K.A. Imaging hypoxia and angiogenesis in tumors. Radiol Clin North Am 43 (2005) 169-187
37. Padhani A. PET imaging of tumour hypoxia. Cancer Imaging 6 (2006) 117-121
38. Chao K.S., Ozyigit G., Blanco A.I., Thorstad W.L., Deasy J.O., Haughey B.H., et al. DG Sessions, Intensity-modulated radiation therapy for oropharyngeal carcinoma: impact of tumor volume. Int J Radiat Oncol Biol Phys 59 (2004) 43-50
39. Obata A., Kasamatsu S., Lewis J.S., Furukawa T., Takamatsu S., Toyohara J., et al. Basic characterization of 64Cu-ATSM as a radiotherapy agent. Nucl Med Biol 32 (2005) 21-28
40. Christian N, Bol A, de Bast M, Labar D, Lee J, Mahy P, et al. Determination of tumour hypoxia with the PET tracer [(18)F]EF3: improvement of the tumour-to-background ratio in a mouse tumour model. Eur J Nucl Med Mol Imaging (in press).
41. Keen H.G., Dekker B.A., Disley L., Hastings D., Lyons S., Reader A.J., et al. Imaging apoptosis in vivo using 124I-annexin V and PET. Nucl Med Biol 32 (2005) 395-402
42. Cai W., Chen K., Mohamed Ali K.A., Cao Q., Gambhir S.S., Rosenblum M.G., et al. PET of vascular endothelial growth factor receptor expression. J Nucl Med 47 (2006) 2048-2056